FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137408524> ?p ?o ?g. }

• W2137408524 endingPage "S367" @default.
• W2137408524 startingPage "S354" @default.
• W2137408524 abstract "This pooled analysis includes 2 phase 3, double-blind trials designed to evaluate the safety and efficacy of tigecycline, versus that of imipenem-cilastatin, in 1642 adults with complicated intra-abdominal infections. Patients were randomized to receive either tigecycline (initial dose of 100 mg, followed by 50 mg intravenously every 12 h) or imipenem-cilastatin (500/500 mg intravenously every 6 h) for 5–14 days. The primary end point was the clinical response at the test-of-cure visit (12–42 days after therapy) in the co-primary end point microbiologically evaluable and microbiological modified intent-to-treat populations. For the microbiologically evaluable group, clinical cure rates were 86.1% (441/512) for tigecycline, versus 86.2% (442/513) for imipenem-cilastatin (95% confidence interval for the difference, -4.5% to 4.4%; P < .0001 for noninferiority). Clinical cure rates in the microbiological modified intent-to-treat population were 80.2% (506/631) for tigecycline, versus 81.5% (514/631) for imipenem-cilastatin (95% confidence interval for the difference, -5.8% to 3.2%; P < .0001 for noninferiority). Nausea (24.4% tigecycline, 19.0% imipenem-cilastatin [P = .01]), vomiting (19.2% tigecycline, 14.3% imipenem-cilastatin [P = .008]), and diarrhea (13.8% tigecycline, 13.2% imipenem-cilastatin [P = .719]) were the most frequently reported adverse events. This pooled analysis demonstrates that tigecycline was efficacious and well tolerated in the treatment of patients with complicated intra-abdominal infections." @default.
• W2137408524 created "2016-06-24" @default.
• W2137408524 creator A5013759582 @default.
• W2137408524 creator A5044798474 @default.
• W2137408524 creator A5052948853 @default.
• W2137408524 creator A5055169513 @default.
• W2137408524 creator A5068770979 @default.
• W2137408524 date "2005-09-01" @default.
• W2137408524 modified "2023-10-07" @default.
• W2137408524 title "The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial Data" @default.
• W2137408524 cites W1560565400 @default.
• W2137408524 cites W1964311223 @default.
• W2137408524 cites W2000521726 @default.
• W2137408524 cites W2007340701 @default.
• W2137408524 cites W2031303083 @default.
• W2137408524 cites W2034482054 @default.
• W2137408524 cites W2069416660 @default.
• W2137408524 cites W2076728316 @default.
• W2137408524 cites W2081535598 @default.
• W2137408524 cites W2083349894 @default.
• W2137408524 cites W2089068120 @default.
• W2137408524 cites W2109434703 @default.
• W2137408524 cites W2113588525 @default.
• W2137408524 cites W2116352191 @default.
• W2137408524 cites W2149365938 @default.
• W2137408524 cites W2153590024 @default.
• W2137408524 cites W2156737450 @default.
• W2137408524 cites W2170206890 @default.
• W2137408524 cites W2402130958 @default.
• W2137408524 doi "https://doi.org/10.1086/431676" @default.
• W2137408524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16080073" @default.
• W2137408524 hasPublicationYear "2005" @default.
• W2137408524 type Work @default.
• W2137408524 sameAs 2137408524 @default.
• W2137408524 citedByCount "345" @default.
• W2137408524 countsByYear W21374085242012 @default.
• W2137408524 countsByYear W21374085242013 @default.
• W2137408524 countsByYear W21374085242014 @default.
• W2137408524 countsByYear W21374085242015 @default.
• W2137408524 countsByYear W21374085242016 @default.
• W2137408524 countsByYear W21374085242017 @default.
• W2137408524 countsByYear W21374085242018 @default.
• W2137408524 countsByYear W21374085242019 @default.
• W2137408524 countsByYear W21374085242020 @default.
• W2137408524 countsByYear W21374085242021 @default.
• W2137408524 countsByYear W21374085242022 @default.
• W2137408524 countsByYear W21374085242023 @default.
• W2137408524 crossrefType "journal-article" @default.
• W2137408524 hasAuthorship W2137408524A5013759582 @default.
• W2137408524 hasAuthorship W2137408524A5044798474 @default.
• W2137408524 hasAuthorship W2137408524A5052948853 @default.
• W2137408524 hasAuthorship W2137408524A5055169513 @default.
• W2137408524 hasAuthorship W2137408524A5068770979 @default.
• W2137408524 hasBestOaLocation W21374085241 @default.
• W2137408524 hasConcept C126322002 @default.
• W2137408524 hasConcept C141071460 @default.
• W2137408524 hasConcept C168563851 @default.
• W2137408524 hasConcept C197934379 @default.
• W2137408524 hasConcept C203092338 @default.
• W2137408524 hasConcept C2777027569 @default.
• W2137408524 hasConcept C2777437143 @default.
• W2137408524 hasConcept C2779631663 @default.
• W2137408524 hasConcept C2781255259 @default.
• W2137408524 hasConcept C2908647359 @default.
• W2137408524 hasConcept C42219234 @default.
• W2137408524 hasConcept C501593827 @default.
• W2137408524 hasConcept C71924100 @default.
• W2137408524 hasConcept C86803240 @default.
• W2137408524 hasConcept C89423630 @default.
• W2137408524 hasConcept C94665300 @default.
• W2137408524 hasConcept C99454951 @default.
• W2137408524 hasConceptScore W2137408524C126322002 @default.
• W2137408524 hasConceptScore W2137408524C141071460 @default.
• W2137408524 hasConceptScore W2137408524C168563851 @default.
• W2137408524 hasConceptScore W2137408524C197934379 @default.
• W2137408524 hasConceptScore W2137408524C203092338 @default.
• W2137408524 hasConceptScore W2137408524C2777027569 @default.
• W2137408524 hasConceptScore W2137408524C2777437143 @default.
• W2137408524 hasConceptScore W2137408524C2779631663 @default.
• W2137408524 hasConceptScore W2137408524C2781255259 @default.
• W2137408524 hasConceptScore W2137408524C2908647359 @default.
• W2137408524 hasConceptScore W2137408524C42219234 @default.
• W2137408524 hasConceptScore W2137408524C501593827 @default.
• W2137408524 hasConceptScore W2137408524C71924100 @default.
• W2137408524 hasConceptScore W2137408524C86803240 @default.
• W2137408524 hasConceptScore W2137408524C89423630 @default.
• W2137408524 hasConceptScore W2137408524C94665300 @default.
• W2137408524 hasConceptScore W2137408524C99454951 @default.
• W2137408524 hasIssue "s5" @default.
• W2137408524 hasLocation W21374085241 @default.
• W2137408524 hasLocation W21374085242 @default.
• W2137408524 hasOpenAccess W2137408524 @default.
• W2137408524 hasPrimaryLocation W21374085241 @default.
• W2137408524 hasRelatedWork W2036173518 @default.
• W2137408524 hasRelatedWork W2036381816 @default.
• W2137408524 hasRelatedWork W2078561636 @default.
• W2137408524 hasRelatedWork W2078824170 @default.
• W2137408524 hasRelatedWork W2137408524 @default.

• next